The treatment of hyperuricemia

International Journal of Cardiology
Micaela GliozziVincenzo Mollace

Abstract

Hyperuricemia has long been established as the major etiologic factor in gout. Alongside with an inflammatory state triggered by urate crystal deposition in the joints, hyperuricemia displayed additional pathophysiological consequences leading to tissue inflammation mainly in the vascular wall. Thus, therapeutic strategies used to treat hyperuricemia in the past decades have often been focused on limiting acute episodes. Recently, evidence has been accumulated suggesting that chronic urate deposition requires a correct treatment not limited to acute episodes based on the modulation of the activity of key enzymes involved in metabolism and excretion of urate including xanthine oxidoreductase (XO) and URAT1. The present review article will try to summarize the most recent evidences on the efficacy of XO inhibitors and uricosuric compounds in lowering uric acid levels in both the bloodstream and peripheral tissues. In particular, we will focus on the effect of novel XO inhibitors in counteracting uric acid overproduction. On the other hand, the effect of lowering uric acid levels via XO inhibition will be correlated with attenuation oxidative stress which leads to endothelial dysfunction thereby contributing to the pathophysiology...Continue Reading

References

May 1, 1992·Archives of Biochemistry and Biophysics·P C PanusB A Freeman
Aug 1, 1995·The Journal of Clinical Investigation·B N CronsteinG Weissmann
Sep 5, 2002·Free Radical Biology & Medicine·Roger Harrison
Dec 25, 2003·The Journal of Physiology·Cristine E Berry, Joshua M Hare
Jul 9, 2004·Drug Metabolism Reviews·Roger Harrison
Dec 9, 2004·Pharmacotherapy·Kerry Wilbur, Mark Makowsky
Jan 30, 2009·Journal of Cellular and Molecular Medicine·Mohanraj RajeshPál Pacher
Jun 12, 2010·Cleveland Clinic Journal of Medicine·Brian F MandellJames C Pile
Dec 27, 2011·QJM : Monthly Journal of the Association of Physicians·E Suresh, P Das
May 17, 2012·Congestive Heart Failure·Arash HarzandJoshua M Hare
Jun 2, 2012·Nature Reviews. Drug Discovery·Joanne Kotz
Nov 24, 2012·Current Pharmaceutical Design·Davide GrassiClaudio Ferri
Jan 5, 2013·Anti-inflammatory & Anti-allergy Agents in Medicinal Chemistry·José Sabán-RuizCristina de la Puerta González-Quevedo
Jan 16, 2013·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Bruce N Cronstein, Prashanth Sunkureddi
Jan 19, 2013·Annual Review of Medicine·Daria B Crittenden, Michael H Pillinger

❮ Previous
Next ❯

Citations

Feb 11, 2016·Drugs·Sheridan M Hoy
Apr 8, 2016·Journal of Enzyme Inhibition and Medicinal Chemistry·Nimet BaltasSevgi Kolayli
Nov 18, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·He TianGuilong Zhao
Nov 15, 2016·Expert Opinion on Therapeutic Patents·Ritu OjhaKunal Nepali
Oct 27, 2017·Current Hypertension Reports·Marilisa BoveClaudio Borghi
Dec 28, 2017·Critical Reviews in Food Science and Nutrition·Arshad MehmoodAmjad Abbas Shah
Nov 8, 2018·Chemical Biology & Drug Design·Arshad MehmoodChengtao Wang
Sep 7, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wugang ZhangHaifang Chen
Jun 20, 2020·Journal of Cellular and Molecular Medicine·Hailong ZhangYuanfang Ma
Jul 10, 2020·Nucleosides, Nucleotides & Nucleic Acids·Xiaowu ZhongXiaolan Guo
Aug 14, 2020·The Journal of Clinical Endocrinology and Metabolism·Yuying WangYingli Lu
Dec 22, 2017·Expert Opinion on Therapeutic Targets·Kyoko Fujita, Kimiyoshi Ichida
Jul 27, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Yansheng WuJiandong Gao
Dec 29, 2018·Journal of the American Heart Association·Kurt W PrinsStephen L Archer
Aug 25, 2019·Nutrients·Stefanos RoumeliotisVassilios Liakopoulos
Aug 11, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Ruirui LiJinyao Chen
Jul 13, 2017·Oxidative Medicine and Cellular Longevity·Ilaria MarroccoIlaria Peluso
Jul 14, 2018·BioMed Research International·Antonella FaisFrancesca Pintus
Apr 10, 2018·Frontiers in Pharmacology·Fazleen I Abu BakarSusi Endrini
Jan 10, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Seung-Hui SongSeung-Sik Cho
Feb 26, 2016·Diseases·Cristina VassalleClara Carpeggiani
Sep 29, 2018·Food Science and Biotechnology·Amalia Di PetrilloAntonella Fais
Dec 18, 2019·Current Vascular Pharmacology·Francesca CorteseMarco Matteo Ciccone
Feb 11, 2021·Pharmaceutics·Jacek RyszAnna Gluba-Brzózka
Jul 12, 2017·Bioorganic & Medicinal Chemistry Letters·Ting-Jian ZhangHua Gao
Apr 16, 2021·Oxidative Medicine and Cellular Longevity·Ning LiuWenjie Lu
May 1, 2021·International Journal of Molecular Sciences·Barbora BoťanskáMiroslav Barančík
Aug 3, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Dongho LeeKwang Il Park
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Takuya NiheiSatomi Onoue

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.